Please assess the completion status of the following clinical trial:

Trial Title: Inhibition of Lipid Peroxidation During Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects, 18 to 80 years of age, scheduled for elective cardiac surgery requiring CPB~2. For female subjects, the following conditions must be met:~postmenopausal for at least 1 year, or status-post surgical sterilization, or if of childbearing potential, utilizing adequate birth control and a negative urine beta-hcg prior to drug treatment~Exclusion Criteria:~1. Allergic reaction to ApAP (acetaminophen)~2. Evidence of severe hepatic impairment (history of liver cirrhosis or total bilirubin \>2.0mg/dl)~3. Impaired renal function (serum creatinine \>2.0 mg/dl)~4. Emergency surgery~5. Pregnancy~6. Breast-feeding~7. Any underlying or acute disease requiring regular medication which could possibly pose a threat to the subject or make implementation of the protocol or interpretation of the study results difficult~8. History of alcohol or drug abuse~9. Treatment with any investigational drug in the 1 month preceding the study~10. Mental conditions rendering the subject unable to understand the nature, scope and possible consequences of the study~11. Inability to comply with the protocol, e.g. uncooperative attitude and unlikelihood of completing the study~12. History or evidence of active asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Acetaminophen (Type: ACTIVE_COMPARATOR): Acetaminophen will ge given as 1g every 6 hours for 4 doses over a 24 hours study period

Based on this trial design, predict the completion outcome and termination type (if applicable).